NAD supports glucosamine claims

NEW YORK — The National Advertising Division of the Council of Better Business Bureaus on Monday reported Direct Digital, marketer of Instaflex, has supported certain advertising claims made in print and online.

Instaflex is formulated with 1,500 mg glucosamine sulfate, 500 mg methylsulfonylmethane, 250 mg ginger root extract and 4 mg hyaluronic acid. Direct Digital had claimed that Instaflex could relieve and comfort joints and increase flexibility, among other claims.

NAD found that the results of the advertiser's glucosamine studies in support of its claims were in line with the National Institute of Health's "Glucosamine/chondroitin Arthritis Intervention Trial." "At this dosage [1,500 mg], NAD has routinely found a reasonable basis for claims that glucosamine 'lubricates,' 'rebuilds,' 'comforts' and increases 'mobility' of joints," the organization stated.

The review was part of NAD's routine monitoring program through a grant from the CRN Foundation.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

Comments

- 3:20 PM
AmyH says

I have suffered from osteoarthritis for years. At first, I took over the counter NSAIDs and Tylenol. My daughter told me about the effects of taking those medications over time so I decided to try alternative supplements. I've been taking Liquid Glucosamine for 3 years now, and rarely ever take pain meds. I've tried many brands, as well as the pill form, and none live up to what my current brand, Synflex Liquid Glucosamine. I've never felt better.

Login or Register to post a comment.